Adia Nutrition Inc. Announces Effectiveness of Form 10 Registration Statement - Now a Fully Reporting SEC Company and Advancing Toward Next Phase of Growth and NASDAQ Uplisting

Core Viewpoint - Adia Nutrition Inc. has achieved a significant milestone by having its Form 10 registration statement become effective, transitioning the company to full reporting status under SEC regulations, which enhances transparency and prepares for potential uplisting to NASDAQ [1][2][3] Group 1: Company Developments - The Form 10 was filed on December 5, 2025, and became effective automatically 60 days later without further SEC review, marking a transition to full reporting status [2] - CEO Larry Powalisz emphasized that this achievement reflects the company's commitment to governance and investor confidence, while also accelerating preparations for uplisting to NASDAQ [3] - The company is expanding its regenerative medicine platform and clinic network, focusing on advanced treatments in stem cell therapy [3] Group 2: Financial and Operational Highlights - Adia Nutrition generates revenue through service fees, product sales, equity stakes, and insurance billing for healthcare treatments [7] - The company is experiencing significant revenue growth and operational expansion in 2025, positioning itself for continued momentum in personalized healthcare [8] - Adia Nutrition is also investing in aligned businesses, such as Cement Factory LLC, which focuses on health and wellness [7] Group 3: Strategic Partnerships and Initiatives - The company is encouraging clinic owners and healthcare practitioners to license the Adia Med name or integrate its regenerative therapies into their practices [5] - Adia Nutrition is forming strategic partnerships to expand access to advanced stem cell solutions [5] - The company is involved in ongoing clinical studies, including an IRB-approved study on autism spectrum disorder using regenerative stem cell therapy [8]